National Institutes of Health, National Cancer Institute, Division of Extramural Activities - Home Page
Skip to Main Content
Search All NCI Board Presentations
BSA & NCAB Joint Meeting Presentations
Home <
Advisory Boards <
BSA <
BSA Meetings <
Home <
Advisory Boards <
NCAB <
NCAB Meetings <
Presentations from the 2
nd
Joint Meeting of the NCI Board of Scientific Advisors (BSA) and the National Cancer Advisory Board (NCAB) - June 15, 2020
June 15
VIDEOCAST
NCI Director's Report
Dr. Sharpless
Legislative Report
Ms. Holohan
Update: COVID–19 Serology and Immunology Capacity Building
Dr. Lowy
NCI-Supported Clinical Research During the COVID-19 Pandemic
Dr. Doroshow
Minority Accrual to NCTN and NCORP Clinical Trials
Dr. McCaskill–Stevens
BSA Childhood Cancer Data Initiative (CCDI) ad hoc Working Group Report
Dr. Shannon
New Cohorts to Assess Environmental Exposures and Cancer Risk (RFA)
Dr. Mahabir
Childhood Cancer Survivorship Study (CCSS) (Re–issue RFA)
Dr. Seibel
Clinical Trials Monitoring Service (CTMS) (RFP)
Mr. Smith
Collaborative Approaches to Engineer Biology for Cancer Applications (RFA/Coop. Agr.)
Dr. Berny–Lang
The NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00) (Re–issue RFA)
Dr. Bogler
Small Business Transition Grant (RFA)
Dr. Hallett
The Cancer Genome Atlas Network: TCGA Genome Characterization (GCCs) and TCGA Genome Data Analysis (GDACs) Centers (Re–issue RFA/Coop. Agr.)
Dr. Zenklusen
PAR Re–issue Concepts
Dr. Gray
Clinical Translation of Activated Optical Fluorescence Methods and Technologies for Sensitive Cancer Detection In Vivo (PAR)
Dr. Nordstrom
Top